Researchers at the University of California, Davis have developed a modular, containerized cooling solution designed to support high‑density computing environments such as data centers and AI clusters. The system combines efficient air‑to‑liquid heat exchange, integrated energy storage options, and intelligent controls to reduce operating costs, improve deployment speed, and enhance system uptime.

Researchers at the University of California, Davis have developed an advanced system that decodes semantic content directly from neural signals to enable natural language communication for users with speech impairments.

Researchers at the University of California, Davis have developed ibogaine-related compounds that promote neural plasticity and treat neuropsychiatric and neurological disorders.

Researchers at the University of California, Davis have developed a targeted gene editing system that reactivates the silenced CDKL5 gene by precise epigenetic modulation to treat CDKL5 deficiency disorder (CDD).

Researchers at the University of California, Davis have developed non-hallucinogenic compounds with clinically relevant therapeutic efficacy that promote neural growth and plasticity.

Researchers at the University of California, Davis have developed a class of compounds intended for the treatment of neurodegenerative diseases such as Alzheimer's by inhibiting DYRK1A kinase and modulating 5-HT2Rs.

Researchers at the University of California, Davis have developed an integrated platform that combines AI-driven computational pathology with 3D-bioprinted, patient-derived tumor models to predict therapeutic response and enable functionally guided precision oncology.

Researchers at the University of California, Davis have developed an unmanned aerial vehicle (UVA) with foldable wings enabling vertical takeoff and landing (VTOL) combined with efficient motorless forward flight.